Kayoko Ito

Dr. Kayoko Ito

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KIKayoko Ito
Kayoko Ito
NINaoko Izumi
Naoko Izumi
SFSaori Funayama
Saori Funayama
KNKaname Nohno
Kaname Nohno
KKKouji Katsura
Kouji Katsura
MIMakoto Inoue
Makoto Inoue
Objective: Side-effects of medications cause xerostomia. There have been cases where a medication has been discontinued owing to its severe side-effects. Therefore, the xerostomia must be treated to ensure that the primary disease is managed effectively. This study analyzed the actual status of patients with medication-induced xerostomia and investigates factors associated with its improvement. Methods: This study assessed 490 patients diagnosed with medication-induced xerostomia who had an unstimulated salivary flow of ≤0.1 mL/min and received treatment for xerostomia at a xerostomia clinic. Patient age, sex, medical history, medications used, disease duration of xerostomia, and psychological disorders were recorded. The anticholinergic burden was assessed using the Anticholinergic Cognitive Burden scale. The unstimulated salivary flow was measured by the spitting method. According to their symptoms and diagnoses, the patients were introduced to oral lubricants, instructed on how to perform massage, and prescribed Japanese herbal medicines, and sialogogues. Factors associated with the subjective improvement of xerostomia and objective changes in the salivary flow rate were recorded at six months. Results: Xerostomia improved in 338 patients (75.3%). The improvement rate was significantly lower in patients with psychiatric disorders (63.6%) (P = 0.009). The improvement rate decreased as more anticholinergics were used (P = 0.018). However, xerostomia improved in approximately 60% of patients receiving three or more anticholinergics. The unstimulated salivary flow increased significantly more in patients who reported an improvement of xerostomia (0.033±0.053 mL/min) than in those who reported no improvement (0.013±0.02 mL/min) (P = 0.025). Conclusion: Xerostomia treatment improved oral dryness in 75.3% of patients receiving xerogenic medications in this study. If xerostomia due to side-effects of medications can be improved by treatment, it will greatly contribute to the quality of life of patients with xerogenic medications and may reduce the number of patients who discontinue medications.

10 January 2018 in Gerodontology
Verified
Journal Article
Closed access
PDF file
MIMasanori Iwasaki
Masanori Iwasaki
WBWenche S. Borgnakke
Wenche S. Borgnakke
AYAkihiro Yoshihara
Akihiro Yoshihara
KIKayoko Ito
Kayoko Ito
HOHiroshi Ogawa
Hiroshi Ogawa
HMHideo Miyazaki
Hideo Miyazaki

30 June 2021 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
TTTomoharu Taga
Tomoharu Taga
KIKayoko Ito
Kayoko Ito
KTKiyoshi Takamatsu
Kiyoshi Takamatsu
MOMariko Ogawa
Mariko Ogawa
SFSaori Funayama
Saori Funayama
MIMakoto Inoue
Makoto Inoue
Background: Perimenopausal women experience a wide variety of systemic symptoms: hot flashes, sweating, mental health concerns and various oral sensory complaints (OSC). OSC in perimenopausal women include xerostomia, taste disturbance and burning mouth. However, the factors associated with these OSC have not been identified. The purpose of this investigation was to elucidate the factors associated with OSC in perimenopausal women.Methods: The study cohort comprised 43 perimenopausal women aged 45–55 years. Data on medical history, medications, menstrual status, menopausal symptoms, quality of life, xerostomia, taste disturbance and burning mouth were collected. Volumes of unstimulated and stimulated saliva were measured. Tongue coating was evaluated according to a tongue coating index. Univariate analysis was performed to identify factors significantly associated with having xerostomia, taste disturbance, burning mouth and more than two OSC (2OSC). Next, the factors strongly associated with these symptoms were examined by logistic regression analysis.Results: The number of menopausal symptoms was significantly higher, and volume of unstimulated saliva was significantly lower in participants with xerostomia, taste disturbance, burning mouth or 2OSC than in those without these characteristics. Agents targeting the central nervous system were more frequently taken by participants with burning mouth and 2OSC than by those without these characteristics. According to logistic regression analysis, the number of menopausal symptoms was an explanatory variable for xerostomia, taste disturbance, burning mouth and 2OSC.Conclusions: Our findings suggested that OSC associated with the number of menopausal symptoms. Management of menopausal symptoms may decrease OSC, leading to improved quality of life of perimenopausal women.

22 January 2021 in Journal of Oral Rehabilitation
Verified
Journal Article
Closed access
PDF file
IKIzumi Kochi
Izumi Kochi
ETEri Takei
Eri Takei
RMRumiko Maeda
Rumiko Maeda
KIKayoko Ito
Kayoko Ito
JMJin Magara
Jin Magara
MIMakoto Inoue
Makoto Inoue

3 July 2020 in Journal of Oral Rehabilitation
Verified
Journal Article
Closed access
PDF file
RMRumiko Maeda
Rumiko Maeda
ETEri Takei
Eri Takei
KIKayoko Ito
Kayoko Ito
JMJin Magara
Jin Magara
TTTakanori Tsujimura
Takanori Tsujimura
MIMakoto Inoue
Makoto Inoue

4 August 2021 in Journal of Oral Rehabilitation
Verified
Journal Article
Closed access
PDF file
WOWakana Onuki
Wakana Onuki
JMJin Magara
Jin Magara
TTTakanori Tsujimura
Takanori Tsujimura
KIKayoko Ito
Kayoko Ito
HSHaruka Sakai
Haruka Sakai
MIMakoto Inoue
Makoto Inoue